Year-over-year, this metric declined by 166.4%, from -$116.00M to -$309.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 56.0% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.22B | $766.00M | $183.00M | $188.00M | -$897.00M | -$266.00M | $607.00M | $15.00M | $50.00M | $580.00M | $298.00M | -$434.00M | -$3.00M | -$350.00M | -$116.00M | $9.76B | $61.00M | $0.00 | -$309.00M |
| QoQ Change | — | -37.0% | -76.1% | +2.7% | -577.1% | +70.3% | +328.2% | -97.5% | +233.3% | >999% | -48.6% | -245.6% | +99.3% | <-999% | +66.9% | >999% | -99.4% | -100.0% | — |
| YoY Change | — | — | — | — | -173.8% | -134.7% | +222.9% | +101.7% | +118.8% | — | -50.9% | <-999% | -106.0% | -160.3% | -138.9% | >999% | >999% | +100.0% | -166.4% |